...
首页> 外文期刊>Neuropharmacology >Coupling to protein kinases A and C of adenosine A(2B) receptors involved in the facilitation of noradrenaline release in the prostatic portion of rat vas deferens.
【24h】

Coupling to protein kinases A and C of adenosine A(2B) receptors involved in the facilitation of noradrenaline release in the prostatic portion of rat vas deferens.

机译:耦合到参与促进大鼠输精管前列腺部分去甲肾上腺素释放的腺苷A(2B)受体的蛋白激酶A和C。

获取原文
获取原文并翻译 | 示例
           

摘要

In the prostatic portion of rat vas deferens, the non-selective adenosine receptor agonist NECA (0.1-30 microM), but not the A(2A) agonist CGS 21680 (0.001-10 microM), caused a facilitation of electrically evoked noradrenaline release (up to [Formula: see text] ), when inhibitory adenosine A(1) receptors were blocked. NECA-elicited facilitation of noradrenaline release was prevented by the A(2B) receptor-antagonist MRS 1754, enhanced by preventing cyclic-AMP degradation with rolipram, abolished by the protein kinase A inhibitors H-89, KT 5720 and cyclic-AMPS-Rp and attenuated by the protein kinase C inhibitors Ro 32-0432 and calphostin C. The adenosine uptake inhibitor NBTI also elicited a facilitation of noradrenaline release; an effect that was abolished by adenosine deaminase and attenuated by MRS 1754, by inhibitors of the extracellular nucleotide metabolism and by blockade of alpha(1)-adrenoceptors and P2X receptors with prazosin and NF023, respectively. It was concluded that adenosine A(2B) receptors are involved in a facilitation of noradrenaline release in the prostatic portion of rat vas deferens that can be activated by adenosine formed by extracellular catabolism of nucleotides. The receptors seem to be coupled to the adenylyl cyclase-protein kinase A pathway but activation of the protein kinase C by protein kinase A, may also contribute to the adenosine A(2B) receptor-mediated facilitation of noradrenaline release.
机译:在大鼠输精管的前列腺部分,非选择性腺苷受体激动剂NECA(0.1-30 microM),而不是A(2A)激动剂CGS 21680(0.001-10 microM)引起电诱发的去甲肾上腺素释放(直至[公式:参见文字]),当抑制性腺苷A(1)受体被阻断时。 NECA诱导去甲肾上腺素释放的促进作用被A(2B)受体拮抗剂MRS 1754阻止,其通过阻止咯利普兰的环AMP降解而增强,被蛋白激酶A抑制剂H-89,KT 5720和环-AMPS-Rp废除腺苷摄取抑制剂NBTI也促进了去甲肾上腺素的释放;并且被蛋白激酶C抑制剂Ro 32-0432和钙磷蛋白C所减弱。腺苷脱氨酶消除了这种作用,MRS 1754减弱了这种作用,细胞外核苷酸代谢的抑制剂又分别用哌唑嗪和NF023阻断了α(1)-肾上腺素受体和P2X受体。结论是,腺苷A(2B)受体参与了大鼠输精管前列腺中去甲肾上腺素的释放,后者可被核苷酸的细胞外分解代谢所形成的腺苷激活。受体似乎耦合到腺苷酸环化酶-蛋白激酶A途径,但蛋白激酶A对蛋白激酶C的激活也可能有助于腺苷A(2B)受体介导的去甲肾上腺素释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号